- Home
- KYTX vs ELA Comparison
KYTX vs ELA Comparison
Compare KYTX & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- ELA
- Stock Information
- Founded
- KYTX 2018
- ELA 1965
- Country
- KYTX United States
- ELA United States
- Employees
- KYTX N/A
- ELA N/A
- Industry
- KYTX
- ELA Consumer Specialties
- Sector
- KYTX
- ELA Consumer Discretionary
- Exchange
- KYTX NYSE
- ELA Nasdaq
- Market Cap
- KYTX 166.4M
- ELA 190.2M
- IPO Year
- KYTX 2024
- ELA N/A
- Fundamental
- Price
- KYTX $3.41
- ELA $7.25
- Analyst Decision
- KYTX Buy
- ELA Strong Buy
- Analyst Count
- KYTX 5
- ELA 1
- Target Price
- KYTX $23.20
- ELA $7.00
- AVG Volume (30 Days)
- KYTX 308.0K
- ELA 14.6K
- Earning Date
- KYTX 02-12-2025
- ELA 03-19-2025
- Dividend Yield
- KYTX N/A
- ELA N/A
- EPS Growth
- KYTX N/A
- ELA N/A
- EPS
- KYTX N/A
- ELA 0.25
- Revenue
- KYTX N/A
- ELA $165,946,534.00
- Revenue This Year
- KYTX N/A
- ELA $1.61
- Revenue Next Year
- KYTX N/A
- ELA $6.30
- P/E Ratio
- KYTX N/A
- ELA $29.72
- Revenue Growth
- KYTX N/A
- ELA N/A
- 52 Week Low
- KYTX $3.22
- ELA $4.16
- 52 Week High
- KYTX $30.60
- ELA $7.88
- Technical
- Relative Strength Index (RSI)
- KYTX 37.34
- ELA 55.80
- Support Level
- KYTX $3.22
- ELA $6.75
- Resistance Level
- KYTX $3.53
- ELA $7.36
- Average True Range (ATR)
- KYTX 0.25
- ELA 0.29
- MACD
- KYTX 0.00
- ELA -0.03
- Stochastic Oscillator
- KYTX 13.46
- ELA 76.93
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About ELA Envela Corporation
Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.